Search

Dr Heng receives a Pfizer-SRI President’s Presenter’s Award as one of the top 25 most meritorious abstracts (either poster or oral presentation) submitted by individuals still in training.

https://www.ualberta.ca/medicine/news/2016/august/new-blood-test-identif...

BIDMC article released Oct 26, 2017

Dr Heng's submission to Challenge titled "Automatic classification of clear cell renal tumors using deep learning: implications for diagnosis and prediction of metastasis" has been selected to receive an award.

Dr Heng's team published the largest histopathological review of transmasculine breast tissues. The aim of the study, published in Modern Pathology, was to clairfy the effect of gender-affirming testosterone therapy in the breast. Press release by BIDMC: https://www.bidmc.org/about-bidmc/news/2020...

Dr. Heng participated in a Power2LeadHER podcast, hosted by Ankita Sundar - a high school sophmore, to talk about her career in academic research. What an honor!

Dr. Heng will be speaking at a health disparity workshop organized by the NCI Center for Cancer Research and the Division of Cancer Epidemiology & Genetics. She will present her group's multidisciplinary research on transgender breast cancer risk and treatment outcomes.

Dr Baker's abstract, " Effect of testosterone therapy on quantitative breast lobular atrophy in transmasculine individuals" has been accepted for a Poster presentation at the Applications of Medical AI Workshop at Medical Image Computing and Computer Assisted Intervention (MICCAI) Meeting, Singapore...

Dr. Heng hosted Dr. Vikrant Kumar, Head of Bioinformatics at Mirxes, for a Harvard Institute of RNA Medicine (HiRM) RNA technologies showcase. Dr. Kumar's talk was about spatially resolved sub-cellular transcriptomics (Stereo-seq) and its applications. How advances in generating high resolution...

Dr. Heng will be presenting a poster, "Plasma miRNAs associated with cisplatin sensitivity in breast cancer" at the 2024 Harvard Institute of RNA Medicine Symposium.